CBD has clearly been a key component of the exponential growth of products associated with wellness and lifestyle. In July, the European Commission announced, however, that it is pausing all pending applications by CBD products for novel food authorisation. In this article on Open Access Government, our client explains what this will mean for the […]
Archive | August, 2020
Keeping secrets: how to protect confidential information and IP
Client NewsIn this article, our client provides an outline of know-how and trade secrets for technology and engineering companies as this is an area that is often in the spotlight, particularly for businesses operating in these sectors. The piece examines the difference between employee knowledge and trade secrets, why it matters and what questions this creates […]
Stop fraud spreading
Client NewsThis feature by our client for members of the Institute of Financial Accountants looks at the risks of any particular frauds that are rising in prevalence at the moment, how accountants can spot the signs in their practice or among clients and gives advice on safeguarding them and their clients.
Clarity and transparency now provided for the sentencing of offenders with mental disorders, developmental disorders or neurological impairments
Client NewsThe coronavirus pandemic has impacted on us all to differing degrees and presented extra challenges. One aspect, experienced by many, is the affect that the enforced changes to our daily lives have had on our mental health. Courts have often struggled to effectively deal with those who fall into this group of offenders. In this […]
Can I “Work From Home” in Another Country?
Client NewsThis article by a Brackenbury client provides guidance to employers from the UK on the potential legal issues associated with the increase in employees asking if they can work from ‘home’ for an extended period in an overseas country, for example, because it is their home nation or their family is based there. The article […]
Artificial Intelligence and Biotechnology
Client NewsFollowing the recent excitement surrounding technologies such as CAR-T therapy and CRISPR, the focus on targeted therapeutics looks set to progress in 2020. This year is likely to witness a continued drive towards personalised medicine within the pharmaceutical and biotech sectors, together with an increased focus on developing the data capture and analytics capabilities necessary for these […]